<http://schema.org/articleBody>
" The NHS needs a system to better judge whether certain drugs are cost-effective, the chief executive of the think tank The King&amp;#039;s Fund has stated. Niall Dickinson admitted that currently the National Institute for Clinical Excellence does a good job making the hard decisions over what drugs the NHS can afford to prescribe. Decisions on drugs should be made on the basis of clinical evidence, Mr Dickinson opined. Speaking on the BBC Radio 4 programme Nice, Mr Dickinson commented: &amp;quot;They [Nice] will have to use some form of cost benefit analysis. There are questions about the exact form that they use, how far for example they take in wider societal benefits. &amp;quot;So you have to look at these things in the round, and you have to look at each one on its own merits, and you have to be very transparent about the way that you do it.&amp;quot; However Mr Dickinson continued that Nice is &amp;quot;a good thing&amp;quot; and England has provided an example to the rest of the world. Meanwhile, the chairman of Nice, Sir Michael Rawlins, has said that the outfit cannot cater to all parties needs and must sometimes make tough decisions. \u00A9 Adfero Ltd "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.netdoctor.co.uk/health-services/nhs/news/a14742/nhs-must-assess-cost-effectiveness-of-drugs/>